#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14130	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2017	693.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	817	C	768	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25352	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3696	684.3	0	.	n	.	0	T695C	SNP	695	695	T	1061	1061	C	740	C,T	690,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25352	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3696	684.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2004	2004	G	869	G,A	827,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25352	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3696	684.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2337	2337	C	833	C,T	791,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25352	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3696	684.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2411	2411	A	838	A	794	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25352	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3696	684.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2963	2963	C	759	C,A	707,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2014	folP	855	855	100.0	folP.l15.c4.ctg.1	1549	129.2	1	SNP	p	R229S	1	.	.	685	687	AGC	985	987	AGC	212;212;216	A;G;C	202;204;204	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5592	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	163.5	1	SNP	p	S91F	1	.	.	271	273	TTC	643	645	TTC	203;203;202	T;T;C	191;191;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5592	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	163.5	1	SNP	p	D95G	1	.	.	283	285	GGC	655	657	GGC	195;189;190	G;G;C	187;181;185	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5592	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3410	163.5	1	SNP	p	G95N	0	.	.	283	285	GGC	655	657	GGC	195;189;190	G;G;C	187;181;185	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1682	mtrR	633	633	99.37	mtrR.l15.c30.ctg.1	1397	120.1	0	.	p	.	0	A78E	NONSYN	232	234	GCA	612	614	GAA	240;239;238	G;A;A	218;222;220	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1682	mtrR	633	633	99.37	mtrR.l15.c30.ctg.1	1397	120.1	0	.	p	.	0	F184L	NONSYN	550	552	TTC	930	932	TTG	182;184;186	T,C;T;G	170,1;175;173	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1682	mtrR	633	633	99.37	mtrR.l15.c30.ctg.1	1397	120.1	1	SNP	p	G45D	0	.	.	133	135	GGC	513	515	GGC	213;213;212	G;G;C	199;198;196	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	872	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1011	85.5	0	.	n	.	0	A197.	DEL	197	197	A	616	616	A	196	A	176	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	182.5	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	182;182;184	G;A;C,T	169;166;171,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	182.5	1	SNP	p	R87I	0	.	.	259	261	CGT	586	588	CGT	185;187;184	C;G;T	176;174;169	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	182.5	1	SNP	p	R87W	0	.	.	259	261	CGT	586	588	CGT	185;187;184	C;G;T	176;174;169	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	182.5	1	SNP	p	S87R	1	.	.	259	261	CGT	586	588	CGT	185;187;184	C;G;T	176;174;169	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5348	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2918	182.5	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	184;186;183	T;C,A;C	173;174,1;174	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4334	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2749	157.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1668	1670	GGC	208;210;209	G,T;G;C	196,1;198;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1262	1264	GCA	200;203;200	G;C;A	184;188;188	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1265	1267	ATC	200;205;205	A;T;C	187;193;193	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1277	1279	GTG	210;211;209	G;T;G	192;195;195	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1277	1279	GTG	210;211;209	G;T;G	192;195;195	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1781	1783	ACC	241;241;240	A;C;C	220;225;225	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1835	1837	GCG	231;229;227	G;C;G	194;183;188	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1835	1837	GCG	231;229;227	G;C;G	194;183;188	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1958	1960	AGC	174;174;173	A;G;C	163;163;164	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1967	1969	GGC	161;159;159	G;G;C	153;152;149	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4032	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2503	160.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1985	1987	CCG	135;135;133	C,G;C,G;G	106,4;103,1;104	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5434	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3154	171.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	201;200;196	C;C;G	180;184;176	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2392	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1786	133.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	483	483	C	186	C	167	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	421	423	GAA	244;241;241	G;A;A	226;223;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	A74V	NONSYN	220	222	GCC	529	531	GTC	210;209;207	G;T;C	197;191;193	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	709	711	GAT	221;226;226	G;A;T	210;214;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	832	834	TCA	208;208;205	T;C;A	191;193;190	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	961	963	GTC	227;227;223	G,T;T;C	210,1;208;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	973	975	TCT	223;220;218	T;C,A;T	214;212,1;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1291	1293	GCA	204;202;201	G;C,A;A	196;195,1;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	1	SNP	p	G120K	1	.	.	358	360	AAG	667	669	AAG	225;225;225	A;A;G	212;215;213	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	1	SNP	p	A121D	1	.	.	361	363	GAC	670	672	GAC	226;227;229	G;A;C	210;215;215	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2752	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1516	179.2	1	SNP	p	D121N	0	.	.	361	363	GAC	670	672	GAC	226;227;229	G;A;C	210;215;215	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10492	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4943	211.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1166	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	993	116.9	1	SNP	p	V57M	1	.	.	169	171	ATG	506	508	ATG	224;223;225	A;T;G	217;214;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
